POST OUTLINE 1) Our process for recovering savings lost to 340B ESP Introduction / Overview Brief history of 340B-related manufacturer restrictions List of manufacturers currently imposing restrictions 2) How VytlOne overcomes 340B ESP restrictions on 340B pricing Establishing communications protocols Ensuring 340B ESP restores prices on schedule Recommendations for further reading Ensuring 340B ESP restores … Read More
A covered entity’s guide to selecting TPAs for its 340B program TPAs play a critical role in any covered entity’s 340B program. It’s their job to match contract pharmacies’ prescription claims with patient data provided by the health systems they serve, to determine 340B eligibility — and generate entity savings. Without those matches, no prescriptions … Read More
Two DOPs Deal With Operations, The 340B Program, And Drug Manufacturers’ Restrictions VytlOne recently organized an introductory Zoom meeting between the DOPs of two health systems we serve. Southwest Mississippi Regional Medical Center’s (SMRMC) Tiffany Poole earned her Doctorate of Pharmacy degree from the University of Mississippi in 2006. A VytlOne pharmacist since 2018, she … Read More
Introducing VytlOne’s 340B Program ROI Calculator The 340B program has often been described, and with good reason, as a black box. There are dozens of factors impacting an individual hospital’s relative success or failure in generating positive returns from a program. VytlOne has optimized dozens of 340B programs — generating over $500 million in savings … Read More
Why specialized software is essential for successful 340B programs As we’ve mentioned in several previous posts, many hospitals taking full advantage of 340B programs’ discounts save millions of dollars a year on prescription costs. However, 340B programs cover thousands of discounted drugs, and, for most eligible entities, thousands — if not tens of thousands — … Read More
For 340B-eligible hospitals dealing with increasingly tight bottom lines (which essentially means all 340B-eligible hospitals), an in-house specialty pharmacy offers enormous savings and revenue potential. Some covered entities generate as much as 600% in specialty pharmacy revenue from 340B drugs as they do in traditional retail / outpatient or contract pharmacy 340B revenue. What is … Read More
As we noted in a previous post, 340B ESP is nothing less than a brazen and (in our opinion) unlawful ploy by the drug manufacturers to evade the discounts they are legally obligated to offer eligible entities — by placing extraordinary, and unnecessary, reporting burdens on hospitals submitting claims for 340B savings. That said, until … Read More
What does it mean for 340B entities’ diminished savings & revenue? As we noted in a previous post, 340B ESP is nothing less than an unlawful ploy by the drug manufacturers to evade the discounts they are legally obligated to offer eligible entities — by placing unnecessary reporting burdens on hospitals submitting claims for 340B … Read More
POST OUTLINE 1) Introduction / Overview 2) What is the 340B Drug Pricing Program? 3) A brief history of 340B ESP The reporting burdens 340B ESP place on covered entities. The real reason behind 340B ESP? 4) How we help eligible entities deal with 340B ESP Reporting your eligible prescriptions to 340B ESP. Tracking your … Read More
What is the Hospital Readmissions Reduction Program? HRRP is a value-based Medicare purchasing program that encourages hospitals to improve communication and care coordination to better engage patients and caregivers in discharge plans and, in turn, prevent avoidable readmissions. According to the Centers for Medicare & Medicaid Services, “Value-based programs reward health care providers with incentive … Read More
